In the context of biliary tract cancer inflammation, immune cells may mitigate immune inflammation, thereby potentially reducing tumor growth and metastatic potential within the tumor microenvironment.Thus, the increased expression of CD4 or CD39 regulatory T cells contributes to dampening inflammation in biliary tract cancer. This evidence concerns the gene CD4 and biliary tract cancer.